ITUA20161663A1 - Derivati chimici del colano per l’uso nel trattamento e/o nella prevenzione delle malattie mediate dai recettori fxr e tgr5/gp-bar1 - Google Patents

Derivati chimici del colano per l’uso nel trattamento e/o nella prevenzione delle malattie mediate dai recettori fxr e tgr5/gp-bar1

Info

Publication number
ITUA20161663A1
ITUA20161663A1 ITUA2016A001663A ITUA20161663A ITUA20161663A1 IT UA20161663 A1 ITUA20161663 A1 IT UA20161663A1 IT UA2016A001663 A ITUA2016A001663 A IT UA2016A001663A IT UA20161663 A ITUA20161663 A IT UA20161663A IT UA20161663 A1 ITUA20161663 A1 IT UA20161663A1
Authority
IT
Italy
Prior art keywords
colano
bar1
tgr5
fxr
receptors
Prior art date
Application number
ITUA2016A001663A
Other languages
English (en)
Inventor
Angela Zampella
Original Assignee
Bar Pharmaceuticals S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bar Pharmaceuticals S R L filed Critical Bar Pharmaceuticals S R L
Priority to ITUA2016A001663A priority Critical patent/ITUA20161663A1/it
Publication of ITUA20161663A1 publication Critical patent/ITUA20161663A1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
ITUA2016A001663A 2016-03-15 2016-03-15 Derivati chimici del colano per l’uso nel trattamento e/o nella prevenzione delle malattie mediate dai recettori fxr e tgr5/gp-bar1 ITUA20161663A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITUA2016A001663A ITUA20161663A1 (it) 2016-03-15 2016-03-15 Derivati chimici del colano per l’uso nel trattamento e/o nella prevenzione delle malattie mediate dai recettori fxr e tgr5/gp-bar1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUA2016A001663A ITUA20161663A1 (it) 2016-03-15 2016-03-15 Derivati chimici del colano per l’uso nel trattamento e/o nella prevenzione delle malattie mediate dai recettori fxr e tgr5/gp-bar1

Publications (1)

Publication Number Publication Date
ITUA20161663A1 true ITUA20161663A1 (it) 2017-09-15

Family

ID=56203710

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUA2016A001663A ITUA20161663A1 (it) 2016-03-15 2016-03-15 Derivati chimici del colano per l’uso nel trattamento e/o nella prevenzione delle malattie mediate dai recettori fxr e tgr5/gp-bar1

Country Status (1)

Country Link
IT (1) ITUA20161663A1 (it)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CLAUDIO D'AMORE ET AL: "Design, Synthesis, and Biological Evaluation of Potent Dual Agonists of Nuclear and Membrane Bile Acid Receptors", JOURNAL OF MEDICINAL CHEMISTRY, vol. 57, no. 3, 13 February 2014 (2014-02-13), pages 937 - 954, XP055165457, ISSN: 0022-2623, DOI: 10.1021/jm401873d *
PELLICCIARI R ET AL: "6alpha-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 45, no. 17, 1 January 2002 (2002-01-01), pages 3569 - 3572, XP002287455, ISSN: 0022-2623, DOI: 10.1021/JM025529G *
T. FUJINO ET AL: "Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation", JOURNAL OF LIPID RESEARCH, vol. 45, no. 1, 1 January 2004 (2004-01-01), US, pages 132 - 138, XP055220806, ISSN: 0022-2275, DOI: 10.1194/jlr.M300215-JLR200 *
Y. IGUCHI ET AL: "Bile alcohols function as the ligands of membrane-type bile acid-activated G protein-coupled receptor", THE JOURNAL OF LIPID RESEARCH, vol. 51, no. 6, 18 December 2009 (2009-12-18), pages 1432 - 1441, XP055165536, ISSN: 0022-2275, DOI: 10.1194/jlr.M004051 *

Similar Documents

Publication Publication Date Title
IL272470A (en) Methods and materials for assessing and treating cancer
HUE054548T2 (hu) Amino-triazolopiridin vegyületek és azok alkalmazása rák kezelésében
HUE061506T2 (hu) Kolán származékok FXR és TGR5/GPBAR1 által közvetített betegségek kezelésében történõ alkalmazásra
SI3681872T1 (sl) Heteroaril substituirani beta-hidroksietilamini za uporabo v zdravljenju hiperglikemije
PL3481846T3 (pl) 11-podstawione 24-hydroksysterole do stosowania w leczeniu stanów związanych z NMDA
HRP20181742T1 (hr) Hidroksialkil-supstituirani derivati feniltriazola i njihova uporaba
HUE061761T2 (hu) Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében
HUE055369T2 (hu) Gyógyászati készítmények cisztás fibrózis transzmembrán konduktancia regulátor kövzetítette betegségek kezelésére
PT3189834T (pt) Utilização de agente de reforço do recetor gabaa na preparação de medicamento sedativo e anestésico
CL2018003444A1 (es) Derivados de adenosina para uso en el tratamiento del cancer.
SI3262037T1 (sl) Novi derivati kinolina za uporabo v zdravljenju in preprečevanju virusnih okužb
ES2711981R1 (es) Aparato y procedimiento para la eliminacion del soporte
PL3381451T3 (pl) Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej
PL3732294T3 (pl) Tymohydrochinon do stosowania w leczeniu hiperglikemii
IT201600084470A1 (it) Composizione per uso nel trattamento del disturbo depressivo maggiore
HRP20181332T1 (hr) Derivati benzimidazola i njihovi farmaceutski pripravci, namijenjeni liječenju upalnih poremećaja
PL3432872T3 (pl) Eflornityna do zastosowania w leczeniu nawracającego/opornego na leczenie temozolomidem gwiaździaka anaplastycznego
PL3236960T3 (pl) Fluralaner do zastosowania w leczeniu demodekozy
DK3153511T3 (da) 2-acylaminothiazolderivat til anvendelse i forebyggelsen eller behandlingen af blære- og urinvejssygdomme
IT201600121601A1 (it) Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo
IL270978B (en) Grape skin for use in the treatment of dysbiosis
DK3452465T3 (da) Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme
IT201600101413A1 (it) Composizione liquida per uso nel trattamento del reflusso gastroesofageo
EP3554314A4 (en) ADJUSTABLE BED FOUNDATION AND RELATED PROCEDURES
IT201700025666A1 (it) Composizione per l’uso nel trattamento dell’ipercolesterolemia e nella prevenzione di patologie cardiovascolari.